ヒアルロン酸フィラー市場：パイプラインレポート（開発段階、セグメント、地域・国、規制経路、主要企業）、2024年最新版

ヒアルロン酸（HA）はグリコサミノグリカン二糖類であり、天然に体内に存在します。HA全体の約50％が皮膚に存在し、真皮線維芽細胞、内皮細胞、滑膜細胞、外膜細胞、平滑筋細胞および卵細胞によって産生されます。HAの注射は顔のしわの減少や軟部組織の増強に用いられます。

当レポートでは、ヒアルロン酸フィラー市場について調査し、製品概要と開発中のパイプライン製品動向、参入企業の最近の動向などを提供しています。

目次

第1章 目次

第2章 イントロダクション

• ヒアルロン酸フィラーの概要

第3章 開発中の製品

• ヒアルロン酸フィラー- 開発段階別のパイプライン製品
• ヒアルロン酸フィラー- セグメント別のパイプライン製品
• ヒアルロン酸フィラー- 地域別のパイプライン製品
• ヒアルロン酸フィラー- 規制経路別のパイプライン製品
• ヒアルロン酸フィラー- 推定承認日別のパイプライン製品
• ヒアルロン酸フィラー- 進行中の臨床試験

第4章 ヒアルロン酸フィラー- 各社が開発中のパイプライン製品

• ヒアルロン酸フィラー企業- 開発段階別のパイプライン製品
• ヒアルロン酸フィラー- 開発段階別のパイプライン製品

第5章 ヒアルロン酸フィラーの企業と製品の概要

• Allergan Aesthetics
• Almirall Ltd
• Aquavit Pharmaceuticals Inc
• BioPlus Co Ltd
• BioSmart Nanotechnology Ltda
• BMG Pharma SpA
• Bmi Korea Co Ltd
• CellPraxis
• Collplant Biotechnologies Ltd
• Croma-Pharma GmbH
• Evolus Inc
• Fillmed Laboratoires
• Hallura Ltd
• Hugel Inc
• Jinwoo Bio Co Ltd
• Laboratoires Vivacy
• LG Chem Ltd
• LifeSprout Inc
• Medytox Inc
• Merz Aesthetics
• Mesoestetic Pharma Group SL
• Oligo Medic Inc
• Q-Med AB
• Shanghai Haohai Biological Technology Co Ltd
• Shin Poong Pharm Co Ltd
• Silk Medical Aesthetics Inc
• Sinclair Pharma Ltd
• SwiftPharma BV
• Teoxane SA
• Tissueform Inc
• TruElastin Laboratories Inc

第6章 ヒアルロン酸フィラー- 最近の動向

第7章 付録

• 調査手法
• GlobalDataについて
• お問合せ
• 免責事項

List of Tables

• Hyaluronic Acid Fillers - Pipeline Products by Stage of Development
• Hyaluronic Acid Fillers - Pipeline Products by Segment
• Hyaluronic Acid Fillers - Pipeline Products by Territory
• Hyaluronic Acid Fillers - Pipeline Products by Regulatory Path
• Hyaluronic Acid Fillers - Pipeline Products by Estimated Approval Date
• Hyaluronic Acid Fillers - Ongoing Clinical Trials
• Hyaluronic Acid Fillers Companies - Pipeline Products by Stage of Development
• Hyaluronic Acid Fillers - Pipeline Products by Stage of Development
• Glossary

List of Figures

• Hyaluronic Acid Fillers - Pipeline Products by Stage of Development
• Hyaluronic Acid Fillers - Pipeline Products by Segment
• Hyaluronic Acid Fillers - Pipeline Products by Territory
• Hyaluronic Acid Fillers - Pipeline Products by Regulatory Path
• Hyaluronic Acid Fillers - Pipeline Products by Estimated Approval Date
• Hyaluronic Acid Fillers - Ongoing Clinical Trials

GlobalData's Medical Devices sector report, "Hyaluronic Acid Fillers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Hyaluronic Acid Fillers pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Hyaluronic Acid (HA) is a glycosaminoglycan disaccharide, which exists naturally in the body. Approximately 50% of total HA is found in the skin, and it is produced by dermal fibroblasts, endothelial cells, synovial cells, adventitial cells, smooth muscle cells, and oocytes. Injections of HA are used for reducing wrinkles in the face and for soft tissue augmentation.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Hyaluronic Acid Fillers under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Hyaluronic Acid Fillers and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Hyaluronic Acid Fillers under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Hyaluronic Acid Fillers Overview

3 Products under Development

• 3.1 Hyaluronic Acid Fillers - Pipeline Products by Stage of Development
• 3.2 Hyaluronic Acid Fillers - Pipeline Products by Segment
• 3.3 Hyaluronic Acid Fillers - Pipeline Products by Territory
• 3.4 Hyaluronic Acid Fillers - Pipeline Products by Regulatory Path
• 3.5 Hyaluronic Acid Fillers - Pipeline Products by Estimated Approval Date
• 3.6 Hyaluronic Acid Fillers - Ongoing Clinical Trials

4 Hyaluronic Acid Fillers - Pipeline Products under Development by Companies

• 4.1 Hyaluronic Acid Fillers Companies - Pipeline Products by Stage of Development
• 4.2 Hyaluronic Acid Fillers - Pipeline Products by Stage of Development

5 Hyaluronic Acid Fillers Companies and Product Overview

• 5.1 Allergan Aesthetics Company Overview
  • 5.1.1 Allergan Aesthetics Pipeline Products & Ongoing Clinical Trials Overview
• 5.2 Almirall Ltd Company Overview
  • 5.2.1 Almirall Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.3 Aquavit Pharmaceuticals Inc Company Overview
  • 5.3.1 Aquavit Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.4 BioPlus Co Ltd Company Overview
  • 5.4.1 BioPlus Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.5 BioSmart Nanotechnology Ltda Company Overview
  • 5.5.1 BioSmart Nanotechnology Ltda Pipeline Products & Ongoing Clinical Trials Overview
• 5.6 BMG Pharma SpA Company Overview
  • 5.6.1 BMG Pharma SpA Pipeline Products & Ongoing Clinical Trials Overview
• 5.7 Bmi Korea Co Ltd Company Overview
  • 5.7.1 Bmi Korea Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.8 CellPraxis Company Overview
  • 5.8.1 CellPraxis Pipeline Products & Ongoing Clinical Trials Overview
• 5.9 Collplant Biotechnologies Ltd Company Overview
  • 5.9.1 Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.10 Croma-Pharma GmbH Company Overview
  • 5.10.1 Croma-Pharma GmbH Pipeline Products & Ongoing Clinical Trials Overview
• 5.11 Evolus Inc Company Overview
  • 5.11.1 Evolus Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.12 Fillmed Laboratoires Company Overview
  • 5.12.1 Fillmed Laboratoires Pipeline Products & Ongoing Clinical Trials Overview
• 5.13 Hallura Ltd Company Overview
  • 5.13.1 Hallura Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.14 Hugel Inc Company Overview
  • 5.14.1 Hugel Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.15 Jinwoo Bio Co Ltd Company Overview
  • 5.15.1 Jinwoo Bio Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.16 Laboratoires Vivacy Company Overview
  • 5.16.1 Laboratoires Vivacy Pipeline Products & Ongoing Clinical Trials Overview
• 5.17 LG Chem Ltd Company Overview
  • 5.17.1 LG Chem Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.18 LifeSprout Inc Company Overview
  • 5.18.1 LifeSprout Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.19 Medytox Inc Company Overview
  • 5.19.1 Medytox Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.20 Merz Aesthetics Company Overview
  • 5.20.1 Merz Aesthetics Pipeline Products & Ongoing Clinical Trials Overview
• 5.21 Mesoestetic Pharma Group SL Company Overview
  • 5.21.1 Mesoestetic Pharma Group SL Pipeline Products & Ongoing Clinical Trials Overview
• 5.22 Oligo Medic Inc Company Overview
  • 5.22.1 Oligo Medic Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.23 Q-Med AB Company Overview
  • 5.23.1 Q-Med AB Pipeline Products & Ongoing Clinical Trials Overview
• 5.24 Shanghai Haohai Biological Technology Co Ltd Company Overview
  • 5.24.1 Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.25 Shin Poong Pharm Co Ltd Company Overview
  • 5.25.1 Shin Poong Pharm Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.26 Silk Medical Aesthetics Inc Company Overview
  • 5.26.1 Silk Medical Aesthetics Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.27 Sinclair Pharma Ltd Company Overview
  • 5.27.1 Sinclair Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.28 SwiftPharma BV Company Overview
  • 5.28.1 SwiftPharma BV Pipeline Products & Ongoing Clinical Trials Overview
• 5.29 Teoxane SA Company Overview
  • 5.29.1 Teoxane SA Pipeline Products & Ongoing Clinical Trials Overview
• 5.30 Tissueform Inc Company Overview
  • 5.30.1 Tissueform Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.31 TruElastin Laboratories Inc Company Overview
  • 5.31.1 TruElastin Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview

6 Hyaluronic Acid Fillers- Recent Developments

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer